Pharmacotherapy Review Course, Pract Exam, and Core Therapeutic Modules Package (No Recert Credit) (Cert # L199330)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/23/2019
Content Release Date: 11/20/2019
Expiration Date: 10/27/2020
Activity Type: Application-based
CE Credits: 32.0 hours (ACPE only)
Activity Fee: $425 (ASHP member); $625 (non-member)

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The review course will be available February 5, 2020. These activities will be recorded during a live educational event on December 7-8, 2019 in Las Vegas, Nevada. Learners who claimed credit for the live activities, should not claim credit for the home study activities.

Target Audience

These activities are intended for pharmacists who are seeking to update their knowledge and skills commensurate with a board certification examination in the areas listed below.

Activity Overview

This online course provides a robust preparatory curriculum for the pharmacy professional preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination. Designed based on the domains, tasks, and knowledge statements developed by the BPS for the certification examination, this course will help you prepare for the exam by identifying areas needed for in‐depth review of pediatric pharmacy issues by:

  • Reviewing pertinent clinical topics and practice skills
  • Providing exam practice questions
  • Listing valuable references for further study

This online course consists of 26 activities (see tables below) and provides up to 32 hours of continuing pharmacy education credit

This course is NOT intended for those obtaining recertification credit. To earn recertification credit, please see courses here: http://elearning.ashp.org/catalog/ptherapy-recert.

These activities are part of the ASHP professional development program.

Review Course

PLEASE NOTE: REVIEW COURSE MATERIAL WILL BE AVAILABLE 2/5/2020.

This course consists of 11 activities (see table below) and provides up to 16 hours of continuing pharmacy education credit. The review course includes case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements. To help you further prepare, this package includes a compilation of practice questions in the same format and rigor to help you prepare for the BPS Specialty Examination.

The review course will be available February 5, 2020. These activities will be recorded during a live educational event on December 8-12, 2019 in Las Vegas, Nevada. Learners who claimed credit for the live activities, should not claim credit for the home study activities.                                  

Learning Module

ACPE Number

Credit Hours

ACPE Expiration Date

Research Design, Methodology, Statistical Analysis, & Application

0204-0000-19-604-H04-P

2.00

12/7/2022

Complex HIV Case

0204-0000-19-605-H02-P

1.50

Medication Safety

0204-0000-19-606-H05-P

1.00

Regulatory and Quality Issues

0204-0000-19-607-H03-P

1.00

Cardiovascular Disease: Secondary Prevention Case #1

0204-0000-19-608-H01-P

1.50

Complex Pediatric Asthma Case

0204-0000-19-609-H01-P

1.50

Cardiovascular Disease: Primary Prevention Case

0204-0000-19-610-H01-P

1.50

Oncology and Supportive Care Case

0204-0000-19-611-H01-P

1.50

Cardiovascular Disease: Secondary Prevention Case #2

0204-0000-19-612-H01-P

1.50

Complex Nursing Home Patient Case

0204-0000-19-613-H01-P

1.50

Complex Pneumonia Case

0204-0000-19-614-H01-P

1.50

                                               

Review Course Learning Objectives

After participating in this CPE activity, learners should be able to:

Research Design, Methodology, Statistical Analysis, and Application

ACPE Number: 0204-0000-19-604-H04-P

  • Analyze biomedical literature with regard to study methodology, statistical analysis, and significance.
  • Explain the use of evidence-based treatment guidelines and protocols.
  • Interpret the biomedical literature and its application to clinical practice.
  • Identify appropriate sources of information to use in addressing questions that arise in one’s practice or from patients and other healthcare professionals.
  • Explain how to provide education regarding the principles and practices of evidence-based medicine to current and future health care professionals.
Complex HIV Case

ACPE Number: 0204-0000-19-605-H02-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including dyslipidemia, and hepatitis B.
  • Identify and manage common drug interactions experienced by HIV-treated patients.
  • Identify and manage common adverse drug reactions experienced by HIV-treated patients.
  • Determine appropriate medication choices for the treatment and prevention of common opportunistic infections.
  • Discuss quality of life issues in terms of medication therapy for HIV-infected patients.
  • Identify and recommend appropriate resource organizations/groups to assist a specific patient.
Medication Safety

ACPE Number: 0204-0000-19-606-H05-P

 At the conclusion of the session the participant should be able to discuss national regulations and local (but universally adopted) practices related to:

  • Adverse drug reaction reporting.
  • Medication safety.
  • Formulary management.
  • Drug development and approval processes.
  • Ethical issues, such as appropriate interactions with industry, conflict of interest disclosures.
Regulatory and Quality Issues

ACPE Number: 0204-0000-19-607-H03-P

At the conclusion of the session the participant should be able to discuss national regulations and local (but universally adopted) practices related to:

  • Quality metrics.
  • Agencies that oversee quality (governmental and non-governmental).
  • Major public health initiatives (e.g., REMS programs, Healthy People 2020, Core Measures).
  • Prescribing and monitoring specific drugs (e.g., methadone, isotretinoin, REMS programs).
  • Federal regulations related to patient’s rights and protections (e.g., privacy, child/adult protective services, advance directives, living will, power of attorney, do not resuscitate)"
Cardiovascular Disease: Secondary Prevention Case #1

ACPE Number: 0204-0000-19-608-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including atrial fibrillation (AF), acute coronary syndromes (ACS), and gastroesophageal reflux disease (GERD).
  • Develop a plan to address continuity of care issues.
  • Formulate a medication therapy plan for smoking cessation.
  • Determine how to manage drug – drug and drug-induced disease interactions in a patient with ischemic heart disease.
  • Discuss quality of life in this population.
  • Discuss national benchmarking standards and implications to patient care.
Complex Pediatric Asthma Case

ACPE Number: 0204-0000-19-609-H01-P

  • Select the optimal treatment and monitoring for a complex patient-case with acute asthma exacerbation, acute otitis media and seasonal allergies.
  • Determine methods for counseling a patient and/or caregiver regarding asthma self-management plan.
  • Formulate a plan for childhood vaccinations in a child who has been delayed in receiving them.
  • Discuss complimentary/alternative medicine and cultural issues in this population.
Cardiovascular Disease: Primary Prevention Case

ACPE Number: 0204-0000-19-610-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including hypertension, dyslipidemia, chronic kidney disease, diabetes, and obesity.
  • State the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recommendations for adult immunizations.
  • Determine how to advise a patient on point-of-care testing to measure response to drug therapy.
  • Discuss national benchmarking standards and implications to patient care.
Oncology and Supportive Care Case

ACPE Number: 0204-0000-19-611-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including breast cancer, febrile neutropenia and pulmonary embolism.
  • Compare and contrast current breast cancer screening recommendations.
  • Develop a plan to manage pain and nausea/vomiting in a patient with cancer.
  • Discuss safety issues in this population.
  • Discuss adherence issues with oral chemotherapy regimens.
Cardiovascular Disease: Secondary Prevention Case #2

ACPE Number: 0204-0000-19-612-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including heart failure, electrolyte disturbances in acute decompensated heart failure, diabetes, and a thyroid disorder.
  • Discuss safety issues and health literacy in this population.
  • Discuss national benchmarking standards and implications to patient care.
Complex Nursing Home Patient Case

ACPE Number: 0204-0000-19-613-H01-P

  • Select the appropriate treatment for a complex patient-case with multiple conditions, including stroke, depression/anxiety, dementia, chronic COPD management, osteoarthritis, osteoporosis, and pain.
  • Discuss complimentary/alternative medicine and safety issues in this population.
  • Discuss quality improvement initiatives and regulations in the nursing home setting.
Complex Pneumonia Case

ACPE Number: 0204-0000-19-614-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including pneumonia, acute renal insufficiency, sepsis, COPD and dehydration.
  • Interpret clinical data, including lab, physical examination and vital signs.
  • Determine and prioritize pneumonia-related treatment goals.
  • Determine approaches to manage drug allergies and select next best drug therapy when primary drugs are precluded. 
  • Discuss approaches to limiting antimicrobial over use by stewarding antibiotic usage appropriately.
  • Discuss safety issues in patients receiving treatment for pneumonia.

Core Therapeutic Modules

The Core Therapeutic Modules Review Package consists of 15 activities (see table below) and provides up to 16 hours of continuing pharmacy education credit. Faculty review clinical topics and practice skills using a case-based approach. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam.

 

Learning Module

ACPE Number

Credit Hours

ACPE Expiration Date

Select Topics in Infectious Diseases: Part 1

0204-0000-19-615-H01-P

1.00

11/19/22

Select Topics in Infectious Diseases: Part 2

0204-0000-19-616-H01-P

1.00

11/19/22

Statistics, Evidence-Based Medicine, and Clinical Trial Design

0204-0000-18-934-H04-P

2.00

05/16/21

Cardiac Arrhythmias and Advanced Cardiac Life Support

0204-0000-19-603-H01-P

1.00

07/16/22

Pharmacotherapy Considerations in the Management of Shock

0204-0000-17-931-H01-P

1.00

05/30/20

Fluid, Electrolytes, and Nutrition

0204-0000-19-602-H01-P

1.00

11/19/22

Select Topics in Men's Health

0204-0000-17-932-H01-P

1.00

05/30/20

Select Topics in Women's Health

0204-0000-18-921-H01-P

1.00

05/22/21

Select Topics in Neurologic Disorders

0204-0000-19-617-H01-P

1.00

11/19/22

Select Topics in Psychiatric Disorders

0204-0000-18-603-H01-P

1.00

08/06/21

Select Topics in Gastrointestinal Diseases

0204-0000-18-922-H01-P

1.00

05/22/21

Select Topics in Rheumatology

0204-0000-18-604-H01-P

1.00

08/06/21

Diabetes

0204-0000-19-618-H01-P

1.00

11/19/22

Heart Failure

0204-0000-18-923-H01-P

1.00

05/23/21

Selected Topics in Renal Disease

0204-0000-18-998-H01-P

1.00

11/14/21

  

Core Therapeutic Learning Objectives

Select Topics in Infectious Diseases: Part 1

ACPE Number: 0204-0000-19-615-H01-P

For the following diseases: C. Difficile infection, skin and soft tissue infections, upper respiratory tract infections, community acquired pneumonia

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment.
Select Topics in Infectious Diseases: Part 2

ACPE Number: 0204-0000-19-616-H01-P

For the following diseases: sexually transmitted diseases, urinary tract infections, endocarditis, meningitis

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment.
Statistics, Evidence-Based Medicine, and Clinical Trial Design

ACPE Number: 0204-0000-18-934-H04-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Determine quality of a study by examining study design, statistical analysis, quality of conclusions, and interpretation of graphs.
  • Determine clinical and statistical significance.
  • Determine if appropriate statistical tests have been used.
  • Determine whether the study applies to a specified patient population.
Cardiac Arrhythmias and Advanced Cardiac Life Support

ACPE Number: 0204-0000-19-603-H01-P

  • Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
  • Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
  • Identify and prevent drug-induced cardiac arrhythmias.
  • Determine the most appropriate therapy and monitoring for cardiac arrhythmias based on patient-specific information and the most current guidelines.
  • Utilize advanced cardiac life support (ACLS) guided therapies.
Pharmacotherapy Considerations in the Management of Shock

ACPE Number: 0204-0000-17-931-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic).
  • Compare and contrast the pharmacologic agents utilized in shock.
  • Determine the most appropriate therapy and monitoring based on patient-specific information and the most current guidelines for the treatment of shock.
Fluid, Electrolytes, and Nutrition

ACPE Number: 0204-0000-19-602-H01-P

Interpret laboratory and diagnostic tests to evaluate fluid, electrolyte and nutrition status.

  • Select the appropriate route for nutrition administration, and evaluate if nutrition needs are being met based on patient-specific information and current guidelines.
  • Manage drug-related electrolyte interactions and nutrient interactions.
  • Determine the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.
Select Topics in Men's Health

ACPE Number: 0204-0000-17-932-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Identify the role of prostate cancer screening and discuss available options for those requiring treatment.
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for patients with benign prostatic hyperplasia, erectile dysfunction and testosterone deficiency. 
  • Provide an overview of screening and treatment of osteoporosis in men.
  • Discuss current recommendations for prevention of HIV transmission in high risk patient populations.
Select Topics in Women's Health

ACPE Number: 0204-0000-18-921-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Identify how drug response differs based on sex.
  • Recommend health screenings based on patient-specific information for osteoporosis, breast cancer, endometrial cancer, and cervical cancer.
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for osteoporosis and menopausal symptoms.
  • Determine which contraceptive options are appropriate based on patient-specific information, including emergency contraception.
  • Recommend safe and effective therapies to use during pregnancy and lactation.
Select Topics in Neurologic Disorders

ACPE Number: 0204-0000-19-617-H01-P

For patients with seizure disorders, Parkinson's Disease, migraine and sleep disorders:

  • Evaluate the risks and benefits of drug therapy considering other medication and patient specific factors.
  • Formulate the most appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines.
  • Manage drug-related problems and evaluate response to therapy.
Select Topics in Psychiatric Disorders

ACPE Number: 0204-0000-18-603-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess benefits and risks of drug therapy considering other medication, and other patient-specific factors. 
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines.
  • Assess available information to identify drug-related problems and response to therapy. 
  • Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.
Select Topics in Gastrointestinal Diseases

ACPE Number: 0204-0000-18-922-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For patients with nausea, vomiting, inflammatory bowel disease, gastroesophageal reflux disease or peptic ulcer disease: Determine the most appropriate treatment and monitoring regimen based on drug-specific variables, patient-specific factors, and clinical practice guidelines.
  • Assess available information to identify drug-related problems and response to drug therapy.
  • Identify appropriate modifications to optimize patient-specific treatment plans based on follow-up assessment.
Select Topics in Rheumatology

ACPE Number: 0204-0000-18-604-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Recommend appropriate ambulatory treatment for a complex patient with rheumatoid arthritis, osteoarthritis or gout.
  • Compare and contrast medications used to manage these conditions.
  • Outline necessary monitoring and safety concerns for medications used to manage these conditions.
Diabetes

ACPE Number: 0204-0000-19-618-H01-P

  • Interpret diagnostic and/or laboratory tests in patients with diabetes.
  • Formulate the most appropriate treatment and monitoring plans, based on patient-specific information and current guidelines for patients with diabetes.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow-up assessment in patients with diabetes.
Heart Failure

ACPE Number: 0204-0000-18-923-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following for patients with heart failure:

  • Interpret diagnostic findings and/or laboratory test results, vital signs, clinical presentation.
  • Determine the most appropriate treatment based on patient-specific information and the most current treatment guidelines.
  • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment.
Selected Topics in Renal Disease

ACPE Number: 0204-0000-18-998-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following for patients with acute kidney injury or chronic kidney disease 

  • Determine the most appropriate treatment and monitoring based on drug characteristics, patient-specific factors, and current clinical practice guidelines.
  • Manage drug dosing and drug-related complications in patients receiving renal replacement therapy.
  • Identify appropriate modifications to the treatment plans based on follow-up assessment to optimize outcomes.

 

Faculty

Full Faculty Bios

Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP*
Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Louisville, Kentucky 
Snehal Bhatt, Pharm.D., BCPS*
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Science
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 
Kalin Clifford, Pharm.D., BCPS, BCGP
Assistant Professor of Pharmacy Practice, Geriatrics & Pediatrics Division
Texas Tech University Health Sciences Center School of Pharmacy
Dallas, Texas 
Stuart Haines, Pharm.D., BCPS, BCACP, BC-ADM
Professor and Director, Pharmacy Professional Development
University of Mississippi School of Pharmacy
Jackson, Mississippi
Meredith Keisler, Pharm.D., BCOP, CPP
Clinical Pharmacist Practitioner, Oncology Supportive Care Consult Service
University of North Carolina Healthcare
Hillsborough, North Carolina
Patricia C. Kienle, R.Ph., M.P.A., FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Systems
Wilkes-Barre, Pennsylvania
Joel Marrs, Pharm.D., BCACP, BCPS-AQ Cardiology, FASHP, FCCP, FNLA
Associate Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado
Clinical Pharmacy Specialist
Denver Health Medical Center
Denver, Colorado
Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID
Associate Professor Midwestern University
Downers Grove, Illinois
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
Douglas Slain, Pharm.D., BCPS, FASHP*
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Canonsburg, Pennsylvania
Kyana D. Stewart, Pharm.D., M.S., BCPS
Infectious Diseases Clinical Pharmacy Specialist
Adult & Pediatric Infectious Diseases
Ochsner Medical Center
New Orleans, Louisiana
Jill Morgan, Pharm.D., BCPS, BCPPS
Associate Professor and Chair for the Department of Pharmacy Practice and Science
University of Maryland
Baltimore, Maryland

*Content matter experts

Reviewers

Susan R. Dombrowski, M.S., R.Ph.
Tony Martin, Pharm.D., M.B.A.
Anna M. Jackson, Pharm.D., BCPS
Kristi Hofer, Pharm.D.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

Christopher Betz: Advisory Board, Portola Pharmaceuticals; Speaker Bureau, Janssen Pharmaceuticals, Inc.

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.